Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -197,878 | -161,525 | -104,080 | -66,423 | -528,628 |
| Depreciation Amortization | 3,356 | 2,322 | 10,143 | 6,586 | 2,081 |
| Accounts receivable | -58,484 | -72,569 | -97,990 | -61,415 | -198,715 |
| Accounts payable and accrued liabilities | 1,089 | -399 | 759 | -10,730 | 170 |
| Other Working Capital | -18,357 | -46,722 | -109,673 | -103,495 | -200,249 |
| Other Operating Activity | 182,408 | 171,667 | 159,519 | 102,494 | 330,606 |
| Operating Cash Flow | $-87,866 | $-107,226 | $-141,322 | $-132,983 | $-594,735 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -403 | -383 | -383 | -293 | -674 |
| Investing Cash Flow | $-403 | $-383 | $-383 | $-293 | $-674 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 365,454 | 365,454 | 365,454 | N/A | N/A |
| Common Stock Issued | 18,828 | 17,188 | 14,632 | 9,477 | 461,039 |
| Other Financing Activity | -235,041 | -229,401 | -229,387 | 98,735 | -66,540 |
| Financing Cash Flow | $149,241 | $153,241 | $150,699 | $108,212 | $394,499 |
| Exchange Rate Effect | -659 | 306 | 133 | -209 | 135 |
| Beginning Cash Position | 352,299 | 352,299 | 352,299 | 352,299 | 553,074 |
| End Cash Position | 412,612 | 398,237 | 361,426 | 327,026 | 352,299 |
| Net Cash Flow | $60,313 | $45,938 | $9,127 | $-25,273 | $-200,775 |
| Free Cash Flow | |||||
| Operating Cash Flow | -87,866 | -107,226 | -141,322 | -132,983 | -594,735 |
| Capital Expenditure | -403 | -383 | -383 | -293 | -773 |
| Free Cash Flow | -88,269 | -107,609 | -141,705 | -133,276 | -595,508 |